BioTech CEO InterviewsXontogeny CEO Chris Garabedian Exclusive Interview [September 2021] BioTech Health XSeptember 26, 2021 As we expand our coverage of the biotechnology sector with the latest biotech news, our team at BioTech… 0 Shares 0 0 0 0 0 0 0
Biotech NewsMacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients Jak ThomsonSeptember 7, 2021 Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically… 4 Shares 4 0 0 0 0 0 0
BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future Jak ThomsonSeptember 3, 2021 About Cel-Sci Corporation Cel-Sci Corporation is a publicly traded biotechnology business which develops, manufactures, and markets treatments focused… 1 Shares 1 0 0 0 0 0 0
Biotech NewsCapricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) BioTech Health XSeptember 3, 2021 Capricor Therapeutics Announces HOPE-2 Trial Data Presentation On September 2nd, Capricor Therapeutics (NASDAQ: CAPR) announced an upcoming company… 1 Shares 1 0 0 0 0 0 0